5V24 | Transferase Transferase Inhibitor | date | Mar 02, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Structure-Based Drug Design Of Novel Ask1 Inhibitors Using A Integrated Lead Optimization Strategy | ||||||||||||||
authors | D.R.Dougan, J.D.Lawson | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Mitogen-Activated Protein Kinase Kinase Kinase 5 Chain: A, B Fragment: Unp Residues 670-940 Synonym: Apoptosis Signal-Regulating Kinase 1,Ask-1,Mapker Kinase 5,Mekk 5; Ec: 2.7.11.25 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Map3k5, Ask1, Mapkkk5, Mekk5 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Rosetta 2(De3) Plyss Expression_system_vector_type: Plasmid Expression_system_plasmid: Peh8 | ||||||||||||||
symmetry | Space Group: P 65 2 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.50 Å | ||||||||||||
ligand | 8V7 | enzyme | Transferase E.C.2.7.11.25 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy., Gibson TS, Johnson B, Fanjul A, Halkowycz P, Dougan DR, Cole D, Swann S, Bioorg Med Chem Lett. 2017 Mar 2. pii: S0960-894X(17)30222-6. doi:, 10.1016/j.bmcl.2017.02.079. PMID:28291695 |
Data retrieval |
View 5V24 in 3D |
Visual 3D analysis of 5V24 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5V24 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |